Asia Pacific: In Asia Pacific, countries such as China, Japan, and South Korea are expected to witness significant growth in the recombinant vaccines market. Increasing investments in healthcare infrastructure, rising awareness about vaccination, and government initiatives to promote immunization are some of the key factors driving market growth in this region.
Europe: The European market for recombinant vaccines, including the United Kingdom, Germany, and France, is also expected to experience steady growth. Strong presence of pharmaceutical companies, high healthcare spending, and favorable government policies supporting vaccination programs are likely to contribute to market growth in this region.